DUBLIN, August 6, 2021 / PRNewswire / – The “Global Drug Delivery Devices Market Report 2021: Implications and Growth of COVID-19 to 2030” report was added to ResearchAndMarkets.com offer.
The 2021 Global Drug Delivery Devices Market report covers this critical market and the impact on it of the COVID-19 virus. It provides strategists, marketers and senior management with the essential information they need to assess the growing demand for drug delivery devices that play a critical role in the treatment of patients with COVID-19.
The main players in the drug delivery device market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc., Baxter International, BD., Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc., Bayer AG and GlaxoSmithKline plc.
The global drug delivery devices market is expected to grow by $ 40.7 billion in 2020 at $ 42.76 billion in 2021 at a compound annual growth rate (CAGR) of 5.1%. The change in growth trend is mainly due to companies stabilizing production after meeting demand which increased exponentially during the COVID-19 pandemic in 2020. The market is expected to reach $ 50.9 billion in 2025 at a CAGR of 4.5%.
The drugs used for the treatment of Covid-19 are both oral and injectable; however, a marginal increase is expected for pulmonary or respiratory drug delivery devices.
Regulatory changes related to medical devices are expected to dampen the growth of the drug delivery devices market. Companies operating in the market are required to adapt to changes in the regulatory framework, which may ultimately limit activity. In addition, companies will have to bear the heavy cost of adapting to changes in the regulatory framework. Also, sudden changes in the regulatory framework related to medical devices can lead to losses, fines, penalties worldwide.
Micro Needle (MN) is a highly efficient and versatile medical device technology, due to its important properties, including painless penetration, low cost, excellent therapeutic efficacy and relative safety. The major players operating in the global micro-needle drug delivery system include, 3M, Vetter Pharma International GmbH, nano Biosciences LLC, Nano Pass and more.
Microneedles are made using biodegradable polymers in which drugs or vaccines are encapsulated in the microneedles. Once the microneedles dissolve in the skin, the drug is released. This new method of delivery allows a wider variety of molecules to cross the skin barrier, thus allowing transdermal delivery to be applied to a wide range of clinical applications, including diabetes, severe osteoporosis, and osteoporosis. influenza vaccination.
The companies in the Drug Delivery Devices market are collaborating with other companies in the industry to strengthen their product portfolio and expand their presence in various geographies. For example, in December 2019, Leo Pharma, a Danish pharmaceutical company, worked with Portal Instruments to create Portal’s advanced needle-free drug delivery system for use in conjunction with LEO Pharma’s research and approved drug portfolio. This simplifies administration and eliminates the need for sharp containers at home, and also decreases the time required for self-injections.
In August 2020, Sulzer, a Swiss-based engineering and manufacturing company, acquired Haselmeier GmbH to $ 118 million. The acquisition of Haselmeier will allow Sulzer to complete its healthcare portfolio, in addition to leveraging its APS expertise in precision injection molding to expand its presence in the drug delivery device market. Haselmeier GmbH, a Swiss-German developer and manufacturer of drug delivery devices.
The increasing prevalence of chronic diseases such as cardiovascular disease, diabetes, cancer, and other diseases is expected to drive the drug delivery devices market. There are different routes of drug administration for drugs. The choice of route depends on three factors: the desired effect; the type of disease and the type of product.
Currently, the development of new drug delivery systems is playing a major role in the pharmaceutical industries. Research and development (R&D) in the field of drug delivery is increasing worldwide due to the increasing prevalence of these diseases.
Most pharmaceutical companies focus on multiple drug delivery technologies to create excellent benefits and better outcomes for their marketed products. Hence, the increasing prevalence of chronic diseases leads to increased consumption of drugs and therapeutic therapies, and this factor is expected to act as a driving force for the growth of the drug delivery devices market.
Main topics covered:
2. Characteristics of the Drug Delivery Device Market
3. Drug Delivery Devices Market Trends and Strategies
4. Impact of COVID-19 on drug delivery devices
5. Drug Delivery Device Market Size and Growth
5.1. Global Historical Drug Delivery Device Market, 2015-2020, in USD Billion
5.1.1. Market pilots
5.1.2. Market restrictions
5.2. Global Drug Delivery Device Forecast Market, 2020-2025F, 2030F, in USD Billion
5.2.1. Market pilots
5.2.2. Market restrictions
6. Drug Delivery Device Market Segmentation
6.1. Global Drug Delivery Device Market, Segmentation by Route, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
- Oral administration of drugs
- Delivery of injectable drugs
- Topical medication administration
- Administration of eye medications
- Administration of pulmonary drugs
- Nasal drug administration
- Administration of drugs by transmucosal route
- Administration of implantable drugs
6.2. Global Drug Delivery Device Market, Patient Care Setting Segmentation, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
- Diagnostic centers
- Ambulatory surgery centers / clinics
- Home care settings
6.3. Global Drug Delivery Device Market, Segmentation by Application, History and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
- Infectious diseases
- Respiratory diseases
- Cardiovascular illnesses
- Autoimmune diseases
- Central nervous system disorders
7. Regional and Country Analysis of Drug Delivery Devices Market
7.1. Global Drug Delivery Device Market, Divided by Region, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
7.2. Global Drug Delivery Device Market, Divided by Country, Historical and Forecast, 2015-2020, 2020-2025F, 2030F, in USD Billion
- F. Hoffmann-La Roche Ltée
- 3M Company
- Pfizer Inc.
- Baxter International
- Novartis AG
- Gerresheimer AG
- Johnson & Johnson Services, Inc.
- Bayer AG
- GlaxoSmithKline plc
- B. Braun Melsungen SA
- Cipla inc.
- Boehringer Ingelheim
- Antares Pharma
- Sulzer SA
- MEDMIX SYSTEMS SA
- Merck & Co., Inc.
- Insulet Corporation
- OraSure Technologies, Inc.
- Activate injections
- Western Pharmaceutical Services, Inc.
- SMC Ltd.
- ViVO Smart Medical Devices Ltd.
- Smith Medical
- CareFusion Corporation
- Abbott Laboratories
- Nipro Company
For more information on this report, visit https://www.researchandmarkets.com/r/upl1ry
Research and markets
Laura Wood, senior
For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716
SOURCE Research and Markets